pharmaphorum

FEBRUARY 21, 2022

Already making inroads as a treatment for HER2-positive breast cancer, AstraZeneca and Daiichi Sankyo’s Enhertu has now shown efficacy in tumours that express lower levels of HER2 – potentially making it an option for a much broader group of patients. It’s a key moment for the two companies, as expansion into HER2-low breast cancer has been held up as a key requirement for Enhertu (trastuzumab deruxtecan) if it is to achieve its multibillion-dollar sales expectations.

Chemotherapy 130

Chemotherapy Labelling 130

Pharma Times

FEBRUARY 24, 2022

No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial

157

157

NY Times

FEBRUARY 8, 2022

A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory.

Vaccines 143

Vaccines Immunity Immunization 143

Outsourcing Pharma

FEBRUARY 3, 2022

A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.

Drug Development 112

Drug Development 112

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Marketing Network

FEBRUARY 10, 2022

Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about engaging oncologists in 2022: 1. Lead with clinical education. It’s no longer enough to build brand awareness, according to the panelists.

Communication 98

Communication 98

Drug Channels

FEBRUARY 1, 2022

The boffins at the Centers for Medicare & Medicaid Services (CMS) recently dropped the latest National Health Expenditure (NHE) data, which measures all U.S. spending on healthcare. (See links below.) These data provide our first official look at how the pandemic has affected U.S. healthcare spending. Today, I examine the key insights from these latest figures.

Hospitals 95

Hospitals 95

Pharma Times

FEBRUARY 21, 2022

The UK government is urged to be more mindful of children and young people who have mental health issues, following the publication of the NHS Elective Recovery Plan

107

107

NY Times

FEBRUARY 4, 2022

Tower Health Medical Group said in a statement that it learned of the allegations on Wednesday. After an investigation, the doctor’s employment was “terminated effective immediately.”.

98

98

Outsourcing Pharma

FEBRUARY 17, 2022

In its forward-looking report on digital health, the consulting outfit offers predictions on what changes are ahead and how they might impact the field.

110

110

Eye on FDA

FEBRUARY 22, 2022

Mask mandates are dropping like flies. Restrictions are being lowered. In my observation, it feels that they are going to the wayside not only because of dropping caseloads, but also because people are just more than ready to move on. There may be some complacence – a feeling that the ubiquitous Omicron has fostered a feeling of inevitability about exposure and eventual infection.

Communication 75

Communication Vaccines 75

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Channels

FEBRUARY 4, 2022

Today’s guest post comes from Jeff Berkowitz, CEO of advisory firm Real Endpoints. Jeff describes problems with Medicare copays that reduce adherence and persistence among seniors. He then describes RE Assist , Real Endpoints’ tech-enabled solution with key information on foundations for more than 30 diseases. To learn more about Medicare copayments and how the RE Assist solution helps patients, register to view Real Endpoints’ free webcast: Solving the Medicare Co-pay Dilemma.

91

91

pharmaphorum

FEBRUARY 21, 2022

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival therapies from AstraZeneca and Johnson & Johnson. The approval is based on the phase 3 FIDELIO-DKD trial, in which Kerendia (finerenone) reduced the risk of kidney disease progression or renal death by 18% when added to the highest tolerated dose of standard therapy.

Diabetes 118

Diabetes 118

Pharma Times

FEBRUARY 15, 2022

Francis Crick Institute and King’s College London collaborate to identify specialist cells which protect DNA

Immunity 132

Immunity Immunization 132

NY Times

FEBRUARY 18, 2022

Beijing once said it had two mRNA shots within reach and ready for approval — one homemade and one produced by a foreign company. Today, neither are available.

Vaccines 98

Vaccines Immunity Immunization 98

Outsourcing Pharma

FEBRUARY 1, 2022

On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.

106

106

Pharma in Brief

FEBRUARY 2, 2022

In a recently published discussion paper , an Advisory Panel (the Panel ) convened by the Canadian Agency for Drugs and Technologies in Health ( CADTH ) presents a proposed framework for a potential pan-Canadian formulary. The Panel is asking for feedback on the framework with an online questionnaire. The feedback will inform a stakeholder session in spring 2022 and the Panel’s final report.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Biosimilars Diabetes 59

Drug Channels

FEBRUARY 11, 2022

Today’s guest post comes from John Beardsley, Senior Vice President of Corporate Strategy at CoverMyMeds. John discusses some of the findings in CoverMyMeds’ recently published report on medication access. He describes patient-centric, data-driven solutions to help patients access, afford, and adhere to their therapies. To learn more, download CoverMyMeds’ 2022 Medication Access Report.

86

86

pharmaphorum

FEBRUARY 3, 2022

India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum. While the regulatory framework for cannabinoid products remains fragmented and hard to navigate around the world, Germany has emerged as an early-mover.

Compounding 114

Compounding 114

Pharma Times

FEBRUARY 18, 2022

New combination treatment can significantly reduce the risk of death among prostate cancer patients

138

138

NY Times

FEBRUARY 11, 2022

The agency will wait for data on whether three doses of Pfizer-BioNTech’s Covid vaccine are effective in young children after new, disappointing data.

Vaccines 97

Vaccines Immunity Immunization 97

Outsourcing Pharma

FEBRUARY 7, 2022

The HIV-focused pharma company announced the agency has approved Cabenuva for administration as few as six times a year for adults living with the virus.

105

105

Drug Patent Watch

FEBRUARY 28, 2022

Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are twenty-seven patents protecting this drug. This drug…. The post New patent for Amicus Therap drug GALAFOLD appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Drug Channels

FEBRUARY 15, 2022

Time to update Drug Channels' exclusive look at independent pharmacy owners’ business economics. Our analysis again reveals that despite what you may have heard, many independent pharmacies continue to hang on in a highly challenging retail environment. Prescription profits remained stable, while the average pharmacy owner’s salary jumped for the second year.

Independent Pharmacies 83

Independent Pharmacies Vaccines 83

pharmaphorum

FEBRUARY 18, 2022

The pandemic-induced transition to digital health is, according to the Nuffield Trust, contributing to an “inverse care law” that’s compounding existing health inequalities. But, as demonstrated by initiatives like the Telehealth Equity Coalition (TEC), the sector is taking a united stand against inequitable access. Technological solutions, from online clinics to app-based long-term condition management, have long been hailed as a solution to problems such as limited capacity and low patient aut

Compounding 109

Compounding 109

Pharma Times

FEBRUARY 22, 2022

The European Commission finds that Servier committed a breach of competition over blood pressure drug

130

130

NY Times

FEBRUARY 10, 2022

Pharmacists and technicians, who have played a critical role in administering Covid-19 tests and vaccines, say they are burned out nearly two years into the pandemic.

Vaccines 89

Vaccines Immunity Immunization 89

Outsourcing Pharma

FEBRUARY 8, 2022

The latest in the Diversity in Oncology series, taking place February 9, will discuss ways academia and community collaboration can narrow representation gaps.

99

99

Drug Patent Watch

FEBRUARY 28, 2022

Annual Drug Patent Expirations for PRISTIQ Pristiq is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from four suppliers. There are two…. The post New patent expiration for Pf Prism drug PRISTIQ appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Drug Channels

FEBRUARY 18, 2022

Today’s guest post comes from Garry Marshall, Senior Director of Business Strategy at Wolters Kluwer, Health. Garry discusses healthcare business vertical integration and its effect on care quality for patients and on providers' work experiences. To learn more, download the Wolters Kluwer Expert Insight article Vertical Integration Strategies: Using Data to Align Partners and Reduce Variation in Care.

82

82

pharmaphorum

FEBRUARY 22, 2022

A study has suggested people with epilepsy may show patterns of activity and behaviour on social media that could serve as an early warning signal for sudden death – a rare but much feared complication of the disease. The study was carried out in six individuals who suffered sudden unexpected death in epilepsy (SUDEP), with the researchers analysing hundreds of Facebook posts for each subject in the six months leading up to their death, with the consent of surviving family members.

108

108

Pharma Times

FEBRUARY 1, 2022

Market authorisation for twice yearly schizophrenia treatment which offers patients much-needed medication continuity

116

116

NY Times

FEBRUARY 10, 2022

The agency threw out previous recommended limits on doses but encouraged “nonopioid therapies” wherever possible.

103

103

Outsourcing Pharma

FEBRUARY 9, 2022

The companyâs analysis of trials conducted around the world last year shows cancers took four of the top five positions, with COVID-19 in second place.

100

100

Drug Patent Watch

FEBRUARY 25, 2022

Annual Drug Patent Expirations for PEPCID+AC Pepcid Ac is a drug marketed by J And J Consumer Inc and is included in three NDAs. It is available from two suppliers.…. The post New patent expiration for J And drug PEPCID AC appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Drug Channels

FEBRUARY 25, 2022

Today’s guest post comes from Jason Zemcik, Vice President of Patient Affordability at TrialCard. Jason discusses two approaches to address the CMS Final Rule on manufacturer coupons and Best Price: the pharmacy copay offer and direct reimbursement to the patient. He goes on to describe TrialCard’s reimbursement capability solutions. To learn more about TrialCard Pay and how to prepare your copay program for the future, register for Solving the Best Price and Co-Pay Challenge – A Framework for A

74

74